编者按：泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016(GUT-HMF2016 & GITAU2016 )于 2016年4月15-17日在天津大礼堂(天津) 成功举行。本届论坛的主题是“泌尿生殖肿瘤与健康长寿之梦”，其宗旨为泌尿生殖肿瘤领域的基础与临床工作者提供有关泌尿生殖肿瘤新知识和新技术的交流平台, 探讨新思路和新方法,提高肿瘤病人的生殖和性功能健康。
小编很荣幸邀请到来自约翰霍普金斯大学医学院的Arthur L. Burnett教授分享阴茎保留及重建手术的管理与治疗方案。
图：Prof. Arthur L. Burnett接受AME编辑采访
1. What is the initial management of penile trauma?
2. What do you think about the medical therapy, radiation therapy and chemotherapy for penile cancer?
3. Is surgical treatment the best option for penile cancer?
4. Any limitation on new surgical procedures for penile cancer?
Arthur L. Burnett, II, MD is Professor, Department of Urology, at Johns Hopkins University School of Medicine, where he is also Director of the Basic Science Laboratory in Neuro-urology. Currently, Dr. Burnett holds professional appointments at the Johns Hopkins Hospital including Director of the Male Consultation Clinic and clinician-scientist at the James Buchanan Brady Urological Institute. Dr. Burnett is recognized for being a world-authority in the science and medicine of male erectile dysfunction. He contributed original discoveries of the nitric oxide biochemical mechanisms in erectile tissue, that paved the way for the clinical development of oral medications to treat erectile dysfunction such as Viagra. He has also pioneered work to develop therapies to protect penile nerve function required for improved erectile function recovery after radical prostatectomy.